US 10555960
Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease
granted A61KA61K31/7036A61K45/06
Quick answer
US patent 10555960 (Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/7036, A61K45/06, A61P, A61P35/00